On February 23, 2021 iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, reported that Michel Detheux, PhD, President and Chief Executive Officer, will present at the upcoming virtual investor conferences in March (Press release, iTeos Therapeutics, FEB 23, 2021, View Source [SID1234575488]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 41st Annual Health Care Conference
Date: Tuesday, March 2, 2021
Time: 11:50 a.m. ET

H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Time: 7:00 a.m. ET

A live webcast of each presentation will be available on the Investors section of the company’s website at View Source An archived replay will be available for approximately 30 days following the presentation.